A survey of GCUK members experiences of taking different branded versions of imatinib has recently been undertaken. Our thanks to all who responded.
Continue reading
Medication News
Generic Imatinib Q&A Bath 2022
Generic imatinib Q & A
Generic Imatinib
Presentation by Dr Ramesh Bulusu & Laura Ferrera on generic imatinib
NICE – Single Technology Appraisal (STA) – Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours – Terminated…
We are very disappointed to report that the NICE single technology appraisal of avapritinib (Ayvakit) for the treatment of unresectable or metastatic PDGFRA D842V-mutant GIST has been terminated. PDGFRA D842V-mutant GIST is an ultra-rare form of GIST affecting 5-10 newly diagnosed GIST cancer patients each year in the UK. After a significant amount of work […]
Continue readingPatients’ Meeting: Treatment of Metastatic GIST ( Leeds, October 2019)
Presentation by Mr Adam Barlow to patients’ meeting, Leeds 2019